Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07158437
PHASE1

Phase 1 Study of SL-325 in Healthy Volunteers

Sponsor: Shattuck Labs, Inc.

View on ClinicalTrials.gov

Summary

This first-in-human study is a randomized, double-blind, placebo-controlled, single-ascending dose and multiple-ascending dose study of SL-325 in healthy volunteers.

Official title: A Randomized, Double-Blind, Placebo-Controlled Single-Ascending Dose and Multiple-Ascending Dose Phase 1 Study of SL-325 in Healthy Volunteers

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

72

Start Date

2025-09

Completion Date

2026-07

Last Updated

2025-09-05

Healthy Volunteers

Yes

Interventions

BIOLOGICAL

SL-325

DR3 blocking antibody

OTHER

Placebo (Normal Saline)

Normal saline

Locations (1)

Celerion

Lincoln, Nebraska, United States